Talus Bioscience Raises $11.2M to Develop Drugs Targeting Undruggable Gene-Regulating Proteins

Seattle biotech Talus Bioscience raised $11.2 million in venture capital to advance its drug discovery platform targeting undruggable gene-regulating proteins linked to diseases. Founded in 2020 by Alex Federation and Lindsay Pino, Talus uses its MARMOT platform and machine learning to study transcription factors within living cells.

TTalus Bio